Glycemic Control and Cholesterol Control Attainment following Acute Coronary Syndrome in Patients with Type 2 Diabetes Mellitus undergoing Percutaneous Coronary Intervention

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20260123003

Enrollment

384

Registered

2026-01-23

Start date

2023-10-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute coronary syndrome, hyperlipidemia, type 2 diabetes mellitus Type 2 diabetes mellitus

Interventions

T2DM and AMI patients who underwent coronary angiography and PCI at The Faculty of Medicine, Vajira Hospital, Navamindradhiraj University, between January 1, 2017, and December 31, 2021.

Prevention

T2DM and AMI patients

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Participants had to be 18 years or older. 2. They were required to have a diagnosis of AMI, including STE-ACS and NSTE-ACS, and to have been treated with PCI. Only data from the first MI occurrence was included for cases where PCI was performed multiple times 3. Participants were required to have a prior diagnosis of T2DM or to receive a T2DM diagnosis during the index admission for PCI. 4. Participants were required to have undergone treatment with LDL-lowering drugs and blood glucose control medication and/or diet control for at least 12 months following the index admission. Laboratory results, including HbA1c and LDL-C levels, had to be available within one month of the index admission. 5. Complete laboratory data including HbA1c, total cholesterol, LDL-C, HDL-C, and triglyceride levels must be available 6- and 12-months post-index admission.

Exclusion criteria

Exclusion criteria: 1. a follow-up period of less than 12 months after the index admission and severe comorbidities or a life expectancy of less than one year, such as advanced cancer or terminal-stage diseases.

Design outcomes

Primary

Measure	Time frame
attainment rates of HbA1c, LDL-C, and non-HDL-C levels meeting target goals in patients with type 2 diabetes who have experienced ACS and were treated with coronary angiography and PCI at 6 months and 12 months after index evenet attainment rates	—

Secondary

Measure	Time frame
Factors predicting the ability to achieve target goals for these patients&#39; HbA1c, LDL-C, and non-HDL-C levels. 6 and 12 months after index event Using statistical analysis	—

Countries

Thailand

Contacts

Public ContactPhanthaphan Sureeyathanaphat

Faculty of Medicine Vajira Hospital, Navamindradhiraj University

phanthaphan@nmu.ac.th022443000

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026